공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 레보노르게스트렐 원료의약품(API) 시장 조사(2020년)

Global Levonorgestrel API Market Research Report 2020

리서치사 QYResearch
발행일 2020년 12월 상품 코드 979825
페이지 정보 영문
가격
US $ 2,900 ₩ 3,364,000 PDF (Single User License)
US $ 4,350 ₩ 5,046,000 PDF (Multi User License)
US $ 5,800 ₩ 6,728,000 PDF (Enterprise Wide License)


세계의 레보노르게스트렐 원료의약품(API) 시장 조사(2020년) Global Levonorgestrel API Market Research Report 2020
발행일 : 2020년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 레보노르게스트렐 원료의약품(API) 시장 규모는 2019년 4,718만 달러로 평가되었으며, 2026년 말까지 5,849만 달러에 달할 것으로 예측됩니다. 2021-2026년간 4.04%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다.

세계의 레보노르게스트렐 API(Levonorgestrel API) 시장에 대해 조사했으며, 주요 기업, 유형·용도·지역별 시장 규모 예측, 주요 기업 개요, 경쟁 구도와 영향요인 분석 등의 정보를 제공합니다.

목차

제1장 레보노르게스트렐 API 시장 개요

  • 제품 개요와 범위
  • 부문 : 유형별
    • 세계의 레보노르게스트렐 API 시장 규모 성장률 분석 : 유형별
    • 단시간 작용형 피임 API
    • 장시간 작용형 피임 API
  • 부문 : 용도별
    • 세계의 레보노르게스트렐 API 판매 비교 : 용도별
    • 레보노르게스트렐 정제
    • 혼합 제품
    • 호르몬 방출 IUD
  • 세계 시장 규모 추정 및 예측
    • 세계의 레보노르게스트렐 API 매출
    • 세계의 레보노르게스트렐 API 판매
    • 레보노르게스트렐 API 시장 규모 : 지역별

제2장 시장 경쟁 : 제조업체별

  • 세계의 레보노르게스트렐 API 시장 판매 점유율 : 제조업체별
  • 세계의 레보노르게스트렐 API 시장 매출 점유율 : 제조업체별
  • 세계의 레보노르게스트렐 API 평균 가격 : 제조업체별
  • 제조업체의 본사, 서비스 지역, 제품 유형
  • 시장 경쟁 상황과 동향
    • 레보노르게스트렐 API 시장 집중률
    • 세계 레보노르게스트렐 API 주요 5개사의 시장 점유율
    • 레보노르게스트렐 API 시장 점유율 : 기업 유형별(Tier 1, Tier 2, Tier 3)
  • 제조업체의 인수합병(M&A) 및 확장 계획

제3장 레보노르게스트렐 API 레트로스페크티브 시장 시나리오 : 지역별

  • 세계의 레보노르게스트렐 API 판매 레트로스페크티브 시장 시나리오 : 지역별
  • 세계의 레보노르게스트렐 API 매출 레트로스페크티브 시장 시나리오 : 지역별
  • 북미의 레보노르게스트렐 API 시장 데이터 : 국가별
    • 북미의 레보노르게스트렐 API 판매량 : 국가별
    • 북미의 레보노르게스트렐 API 매출 : 국가별
    • 미국
    • 캐나다
    • 멕시코
  • 유럽의 레보노르게스트렐 API 시장 데이터 : 국가별
    • 유럽의 레보노르게스트렐 API 판매량 : 국가별
    • 유럽의 레보노르게스트렐 API 매출 : 국가별
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아
  • 아시아태평양의 레보노르게스트렐 API 시장 데이터 : 국가별
    • 아시아태평양의 레보노르게스트렐 API 판매량 : 지역별
    • 아시아태평양의 레보노르게스트렐 API 매출 : 지역별
    • 중국
    • 일본
    • 한국
    • 인도
    • 호주
    • 동남아시아
  • 남미 레보노르게스트렐 API 시장 데이터 : 국가별
    • 남미의 레보노르게스트렐 API 판매량 : 국가별
    • 남미의 레보노르게스트렐 API 매출 : 국가별
    • 브라질
    • 콜롬비아
    • 아르헨티나
  • 중동 및 아프리카의 레보노르게스트렐 API 시장 데이터 : 국가별
    • 중동 및 아프리카의 레보노르게스트렐 API 판매량 : 국가별
    • 중동 및 아프리카의 레보노르게스트렐 API 매출 : 국가별
    • 중동
    • 아프리카

제4장 세계의 레보노르게스트렐 API 시장 실적 분석 : 유형별

  • 판매 점유율 : 유형별
  • 매출 점유율 : 유형별
  • 가격 : 유형별

제5장 세계의 레보노르게스트렐 API 시장 실적 분석 : 용도별

  • 판매 점유율 : 용도별
  • 매출 점유율 : 용도별

제6장 기업 개요 및 주요 데이터

  • Bayer HealthCare
  • Qinhuangdao Zizhu Pharmaceutical
  • Yangzhou Pharmaceutical
  • Lupin
  • Hubei Gedian Humanwell
  • Sterling Spa
  • Formos
  • Huazhong Pharm
  • ASG Biochem

제7장 제조 비용 분석

  • R&D 비용 분석
  • 제조 비용 구조
  • 제조 공정 분석
  • 산업 체인 분석

제8장 마케팅 채널, 유통업체, 고객

  • 마케팅 채널
  • 유통업체 리스트
  • 고객

제9장 레보노르게스트렐 API 시장 역학

  • 시장 동향
  • 기회와 성장 촉진요인
  • 시장이 해결해야 할 과제
  • Porter의 산업 분석

제10장 세계 시장 예측

  • 레보노르게스트렐 API 시장 추정 및 예측 : 유형별
    • 세계의 레보노르게스트렐 API 판매 예측 : 유형별
    • 세계의 레보노르게스트렐 API 매출 예측 : 유형별
  • 용도별
  • 지역별
    • 세계의 레보노르게스트렐 API 판매 예측 : 지역별
    • 세계의 레보노르게스트렐 API 매출 예측 : 지역별

제11장 조사 결과 및 결론

제12장 조사 방법과 데이터 소스

LSH 21.01.12

List of Tables and Figures

  • Table 1. Global Levonorgestrel API Sales (Kg), Value (US$ Thousand):Growth Rate Comparison by Type (2020-2026)
  • Table 2. Global Levonorgestrel API Sales (Kg) Comparison by Application (2020-2026)
  • Table 3. Global Levonorgestrel API Market Size by Region & (US$ Thousand): 2020 VS 2026
  • Table 4. Key Manufacturers Levonorgestrel API Covered in This Study
  • Table 5. Global Levonorgestrel API Sales (Kg) of Key Manufacturers (2019-2020)
  • Table 6. Global Levonorgestrel API Sales Market Share by Manufacturers (2019-2020)
  • Table 7. Global Levonorgestrel API Revenue (US$ Thousand) by Manufacturers (2019-2020)
  • Table 8. Global Levonorgestrel API Revenue Share by Manufacturers (2019-2020)
  • Table 9. Global Market Levonorgestrel API Average Price (USD/KG) of Key Manufacturers (2019-2020)
  • Table 10. Manufacturers Levonorgestrel API Headquarters and Established Data
  • Table 11. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 12. Global Levonorgestrel API by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Levonorgestrel API as of 2019)
  • Table 13. Global Levonorgestrel API Sales by Region (2015-2020) & (Kg)
  • Table 14. Global Levonorgestrel API Sales Market Share by Region (2015-2020)
  • Table 15. Global Levonorgestrel API Revenue by Region (2015-2020) & (US$ Thousand)
  • Table 16. North America Levonorgestrel API Sales by Country (2015-2020) & (Kg)
  • Table 17. North America Levonorgestrel API Sales Market Share by Country (2015-2020)
  • Table 18. North America Levonorgestrel API Revenue by Country (2015-2020) & (US$ Thousand)
  • Table 19. North America Levonorgestrel API Revenue Market Share by Country (2015-2020)
  • Table 20. Europe Levonorgestrel API Sales by Country (2015-2020) & (Kg)
  • Table 21. Europe Levonorgestrel API Sales Market Share by Country (2015-2020)
  • Table 22. Europe Levonorgestrel API Revenue by Country (2015-2020) & (US$ Thousand)
  • Table 23. Europe Levonorgestrel API Revenue Market Share by Country (2015-2020)
  • Table 24. Asia Pacific Levonorgestrel API Sales by Region (2015-2020) & (Kg)
  • Table 25. Asia Pacific Levonorgestrel API Sales Market Share by Region (2015-2020)
  • Table 26. Asia Pacific Levonorgestrel API Revenue by Region (2015-2020) & (US$ Thousand)
  • Table 27. Asia Pacific Levonorgestrel API Revenue Market Share by Region (2015-2020)
  • Table 28. South America Levonorgestrel API Sales by Country (2015-2020) & (Kg)
  • Table 29. South America Levonorgestrel API Sales Market Share by Country (2015-2020)
  • Table 30. South America Levonorgestrel API Revenue by Country (2015-2020) & (US$ Thousand)
  • Table 31. South America Levonorgestrel API Revenue Market Share by Country (2015-2020)
  • Table 32. Middle East and Africa Levonorgestrel API Sales by Country (2015-2020) & (Kg)
  • Table 33. Middle East and Africa Levonorgestrel API Sales Market Share by Country (2015-2020)
  • Table 34. Middle East and Africa Levonorgestrel API Revenue by Country (2015-2020) & (US$ Thousand)
  • Table 35. Middle East and Africa Levonorgestrel API Revenue Market Share by Country (2015-2020)
  • Table 36. Global Levonorgestrel API Sales (Kg) by Type (2015-2020)
  • Table 37. Global Levonorgestrel API Sales Market Share by Type (2015-2020)
  • Table 38. Global Levonorgestrel API Revenue (US$ Thousand) by Type (2015-2020)
  • Table 39. Global Levonorgestrel API Revenue Share by Type (2015-2020)
  • Table 40. Global Levonorgestrel API Price (USD/KG) by Type (2015-2020)
  • Table 41. Global Levonorgestrel API Sales (Kg) by Application (2015-2020)
  • Table 42. Global Levonorgestrel API Sales Share by Application (2015-2020)
  • Table 43. Bayer HealthCare Corporation Information
  • Table 44. Bayer HealthCare Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/KG) and Gross Margin (2019-2020)
  • Table 45. Qinhuangdao Zizhu Pharmaceutical Corporation Information
  • Table 46. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 47. Yangzhou Pharmaceutical Corporation Information
  • Table 48. Yangzhou Pharmaceutical Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 49. Lupin Company Profile
  • Table 50. Lupin Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)2019-2020
  • Table 51. Hubei Gedian Humanwell Corporation Information
  • Table 52. Hubei Gedian Humanwell Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 53. Sterling Spa Corporation Information
  • Table 54. Sterling Spa Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 55. Formos Corporation Information
  • Table 56. Formos Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 57. Huazhong Pharm Corporation Information
  • Table 58. Huazhong Pharm Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 59. ASG Biochem Corporation Information
  • Table 60. ASG Biochem Levonorgestrel API Sales (Kg), Revenue (US$ Thousand), Price (USD/Kg) and Gross Margin (2019-2020)
  • Table 61. Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
  • Table 62. Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Table 63. Levonorgestrel API Distributors List
  • Table 64. Levonorgestrel API Customers List
  • Table 65. Levonorgestrel API Market Trends
  • Table 66. Levonorgestrel API Opportunities and Drivers
  • Table 67. Levonorgestrel API Market Challenges
  • Table 68. Global Levonorgestrel API Sales Forecast by Type (2021-2026) & (Kg)
  • Table 69. Global Levonorgestrel API Sales Market Share Forecast by Type (2021-2026)
  • Table 70. Global Levonorgestrel API Revenue Forecast by Type (2021-2026) & (US$ Thousand)
  • Table 71. Global Levonorgestrel API Revenue Market Share Forecast by Type (2021-2026)
  • Table 72. Global Levonorgestrel API Sales Forecast by Application (2021-2026) & (Kg)
  • Table 73. Global Levonorgestrel API Sales Market Share Forecast by Application (2021-2026)
  • Table 74. Global Levonorgestrel API Sales Forecast by Region (2021-2026) & (Kg)
  • Table 75. Global Levonorgestrel API Sales Market Share Forecast by Region (2021-2026)
  • Table 76. Global Levonorgestrel API Revenue Forecast by Region (2021-2026) & (US$ Thousand)
  • Table 77. Global Levonorgestrel API Revenue Market Share Forecast by Region (2021-2026)
  • Table 78. Research Programs/Design for This Report
  • Table 79. Key Data Information from Secondary Sources
  • Table 80. Key Data Information from Primary Sources
  • Figure 1. Product Picture of Levonorgestrel API
  • Figure 2. Global Levonorgestrel API Market Share by Type in 2020
  • Figure 3. Global Levonorgestrel API Market Share by Type in 2026
  • Figure 4. Short-Acting Contraceptive API Product Picture
  • Figure 5. Long-Acting Contraceptive API Product Picture
  • Figure 6. Global Levonorgestrel API Market Share by Application in 2020
  • Figure 7. Global Levonorgestrel API Market Share by Application in 2026
  • Figure 8. Levonorgestrel Tablet
  • Figure 9. Mixture Products
  • Figure 10. Hormone-releasing IUD
  • Figure 11. Global Levonorgestrel API Revenue (US$ Thousand), 2015 VS 2020 VS 2026
  • Figure 12. Global Levonorgestrel API Revenue 2015-2026 (US$ Thousand)
  • Figure 13. Global Levonorgestrel API Sales 2015-2026 (Kg)
  • Figure 14. Global Levonorgestrel API Market Size Market Share by Region: 2020 Versus 2026
  • Figure 15. Levonorgestrel API Sales Share by Manufacturers in 2019
  • Figure 16. Global Levonorgestrel API Revenue Share by Manufacturers in 2019
  • Figure 17. Figure Global 5 Largest Levonorgestrel API Players: Market Share by Revenue in Levonorgestrel API in 2019
  • Figure 18. Global Levonorgestrel API Sales Market Share by Region (2015-2020)
  • Figure 19. Global Levonorgestrel API Sales Market Share by Region in 2019
  • Figure 20. Global Levonorgestrel API Revenue Market Share by Region (2015-2020)
  • Figure 21. Global Levonorgestrel API Revenue Market Share by Region in 2019
  • Figure 22. North America Levonorgestrel API Sales Market Share by Country in 2019
  • Figure 23. North America Levonorgestrel API Revenue Market Share by Country in 2019
  • Figure 24. United States Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 25. Canada Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 26. Mexico Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 27. Europe Levonorgestrel API Revenue Market Share by Country in 2019
  • Figure 28. Germany Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 29. France Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 30. U.K. Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 31. Italy Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 32. Russia Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 33. Asia Pacific Levonorgestrel API Revenue Market Share by Region in 2019
  • Figure 34. China Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 35. Japan Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 36. South Korea Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 37. India Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 38. Australia Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 39. Southeast Asia Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 40. Brazil Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 41. Colombia Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 42. Argentina Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 43. Middle East Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 44. Africa Levonorgestrel API Revenue Growth Rate (2015-2020) & (US$ Thousand)
  • Figure 45. Sales Market Share of Levonorgestrel API by Type (2015-2020)
  • Figure 46. Sales Market Share of Levonorgestrel API by Type in 2019
  • Figure 47. Revenue Share of Levonorgestrel API by Type (2015-2020)
  • Figure 48. Revenue Market Share of Levonorgestrel API by Type in 2019
  • Figure 49. Sales Share of Levonorgestrel API by Application (2015-2020)
  • Figure 50. Revenue Market Share of Levonorgestrel API by Application in 2019
  • Figure 51. Bayer HealthCare Levonorgestrel API Product
  • Figure 52. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product
  • Figure 53. Yangzhou Pharmaceutical Levonorgestrel API Product
  • Figure 54. Levonorgestrel API Product Picture of Lupin
  • Figure 55. Hubei Gedian Humanwell Levonorgestrel API Product
  • Figure 56. Sterling Spa Levonorgestrel API Product
  • Figure 57. Formos Levonorgestrel API Product
  • Figure 58. Huazhong Pharm Levonorgestrel API Product
  • Figure 59. ASG Biochem Levonorgestrel API Product
  • Figure 60. Manufacturing Cost Structure of Levonorgestrel API
  • Figure 61. Manufacturing Process Analysis of Levonorgestrel API
  • Figure 62. Levonorgestrel API Industrial Chain Analysis
  • Figure 63. Channels of Distribution
  • Figure 64. Distributors Profiles
  • Figure 65. Porter's Five Forces Analysis
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed 86

The global Levonorgestrel API market was valued at US$ 47.18 million in 2019 and it is expected to reach US$ 58.49 million by the end of 2026, growing at a CAGR of 4.04% during 2021-2026.

This report focuses on Levonorgestrel API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Levonorgestrel API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Levonorgestrel API Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Bayer HealthCare
  • Qinhuangdao Zizhu Pharmaceutical
  • Yangzhou Pharmaceutical
  • Lupin
  • Hubei Gedian Humanwell
  • Sterling Spa
  • Formos
  • Huazhong Pharm
  • ASG Biochem

Segment by Type

  • Short-Acting Contraceptive API
  • Long-Acting Contraceptive API

Segment by Application

  • Levonorgestrel Tablet
  • Mixture Products
  • Hormone-releasing IUD

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Southeast Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • South America
  • Brazil
  • Colombia
  • Argentina
  • Middle East & Africa
  • Middle East
  • Africa
  • U.A.E

TABLE OF CONTENTS

1 LEVONORGESTREL API MARKET OVERVIEW

  • 1.1 Product Overview and Scope of Levonorgestrel API
  • 1.2 Levonorgestrel API Segment by Type
    • 1.2.1 Global Levonorgestrel API Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Short-Acting Contraceptive API
    • 1.2.3 Long-Acting Contraceptive API
  • 1.3 Levonorgestrel API Segment by Application
    • 1.3.1 Global Levonorgestrel API Sales Comparison by Application (2020-2026)
    • 1.3.2 Levonorgestrel Tablet
    • 1.3.3 Mixture Products
    • 1.3.4 Hormone-releasing IUD
  • 1.4 Global Levonorgestrel API Market Size Estimates and Forecasts
    • 1.4.1 Global Levonorgestrel API Revenue 2015-2026
    • 1.4.2 Global Levonorgestrel API Sales 2015-2026
    • 1.4.3 Levonorgestrel API Market Size by Region: 2020 Versus 2026

2 GLOBAL LEVONORGESTREL API MARKET COMPETITION BY MANUFACTURERS

  • 2.1 Global Levonorgestrel API Sales Market Share by Manufacturers (2019-2020)
  • 2.2 Global Levonorgestrel API Revenue Market Share by Manufacturers (2019-2020)
  • 2.3 Global Levonorgestrel API Average Price by Manufacturers (2019-2020)
  • 2.4 Manufacturers Levonorgestrel API Headquarters and Established Data
  • 2.5 Levonorgestrel API Market Competitive Situation and Trends
    • 2.5.1 Levonorgestrel API Market Concentration Rate
    • 2.5.2 The Global 5 Largest Levonorgestrel API Players Market Share by Revenue
    • 2.5.3 Global Levonorgestrel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 LEVONORGESTREL API RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 Global Levonorgestrel API Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Levonorgestrel API Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Levonorgestrel API Market Facts & Figures by Country
    • 3.3.1 North America Levonorgestrel API Sales by Country
    • 3.3.2 North America Levonorgestrel API Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
    • 3.3.5 Mexico
  • 3.4 Europe Levonorgestrel API Market Facts & Figures by Country
    • 3.4.1 Europe Levonorgestrel API Sales by Country
    • 3.4.2 Europe Levonorgestrel API Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Levonorgestrel API Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Levonorgestrel API Sales by Region
    • 3.5.2 Asia Pacific Levonorgestrel API Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Southeast Asia
  • 3.6 South America Levonorgestrel API Market Facts & Figures by Country
    • 3.6.1 South America Levonorgestrel API Sales by Country
    • 3.6.2 South America Levonorgestrel API Revenue by Country
    • 3.6.3 Brazil
    • 3.6.4 Colombia
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Levonorgestrel API Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Levonorgestrel API Sales by Country
    • 3.7.2 Middle East and Africa Levonorgestrel API Revenue by Country
    • 3.7.3 Middle East
    • 3.7.4 Africa

4 GLOBAL LEVONORGESTREL API HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 Global Levonorgestrel API Sales Market Share by Type (2015-2020)
  • 4.2 Global Levonorgestrel API Revenue Market Share by Type (2015-2020)
  • 4.3 Global Levonorgestrel API Price by Type (2015-2020)

5 GLOBAL LEVONORGESTREL API HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 Global Levonorgestrel API Sales by Application (2015-2020)
  • 5.2 Global Levonorgestrel API Sales Market Share by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN LEVONORGESTREL API BUSINESS

  • 6.1 Bayer HealthCare
    • 6.1.1 Bayer HealthCare Corporation Information
    • 6.1.2 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.1.3 Bayer HealthCare Levonorgestrel API Products Offered
  • 6.2 Qinhuangdao Zizhu Pharmaceutical
    • 6.2.1 Qinhuangdao Zizhu Pharmaceutical Corporation Information
    • 6.2.2 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Products Offered
  • 6.3 Yangzhou Pharmaceutical
    • 6.3.1 Yangzhou Pharmaceutical Corporation Information
    • 6.3.2 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.3.3 Yangzhou Pharmaceutical Levonorgestrel API Products Offered
  • 6.4 Lupin
    • 6.4.1 Company Profile
    • 6.4.2 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)n
    • 6.4.3 Product Information
  • 6.5 Hubei Gedian Humanwell
    • 6.5.1 Hubei Gedian Humanwell Corporation Information
    • 6.5.2 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.5.3 Hubei Gedian Humanwell Levonorgestrel API Products Offered
  • 6.6 Sterling Spa
    • 6.6.1 Sterling Spa Corporation Information
    • 6.6.2 Sterling Spa Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.6.3 Sterling Spa Levonorgestrel API Products Offered
  • 6.7 Formos
    • 6.7.1 Formos Corporation Information
    • 6.7.2 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.7.3 Formos Levonorgestrel API Products Offered
  • 6.8 Huazhong Pharm
    • 6.8.1 Huazhong Pharm Corporation Information
    • 6.8.2 Huazhong Pharm Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.8.3 Huazhong Pharm Levonorgestrel API Products Offered
  • 6.9 ASG Biochem
    • 6.9.1 ASG Biochem Corporation Information
    • 6.9.2 ASG Biochem Levonorgestrel API Sales, Revenue and Gross Margin (2019-2020)
    • 6.9.3 ASG Biochem Levonorgestrel API Products Offered

7 LEVONORGESTREL API MANUFACTURING COST ANALYSIS

  • 7.1 Levonorgestrel API R&D Cost Analysis
    • 7.1.1 Clinical Phase Costs
    • 7.1.2 Capitalized Costs
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Levonorgestrel API
  • 7.4 Levonorgestrel API Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 Marketing Channel
  • 8.2 Levonorgestrel API Distributors List
  • 8.3 Levonorgestrel API Customers

9 LEVONORGESTREL API MARKET DYNAMICS

  • 9.1 Levonorgestrel API Market Trends
  • 9.2 Levonorgestrel API Opportunities and Drivers
  • 9.3 Levonorgestrel API Market Challenges
  • 9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

  • 10.1 Levonorgestrel API Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Levonorgestrel API by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Levonorgestrel API by Type (2021-2026)
  • 10.2 Levonorgestrel API Market Estimates and Projections by Application
  • 10.3 Levonorgestrel API Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Levonorgestrel API by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Levonorgestrel API by Region (2021-2026)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 Methodology/Research Approach
    • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
  • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
  • 12.3 Author List
  • 12.4 Disclaimer
Back to Top
전화 문의
F A Q